DD219200A5 - Verfahren zur herstellung neuer 6alpha-methylkortikoide - Google Patents

Verfahren zur herstellung neuer 6alpha-methylkortikoide Download PDF

Info

Publication number
DD219200A5
DD219200A5 DD83256872A DD25687283A DD219200A5 DD 219200 A5 DD219200 A5 DD 219200A5 DD 83256872 A DD83256872 A DD 83256872A DD 25687283 A DD25687283 A DD 25687283A DD 219200 A5 DD219200 A5 DD 219200A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
dione
hydroxy
general formula
acetoxy
Prior art date
Application number
DD83256872A
Other languages
German (de)
English (en)
Inventor
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Hans Wendt
Original Assignee
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Hans Wendt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klaus Annen, Henry Laurent, Helmut Hofmeister, Rudolf Wiechert, Hans Wendt filed Critical Klaus Annen
Publication of DD219200A5 publication Critical patent/DD219200A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Seasonings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Tobacco Products (AREA)
DD83256872A 1982-11-22 1983-11-18 Verfahren zur herstellung neuer 6alpha-methylkortikoide DD219200A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823243482 DE3243482A1 (de) 1982-11-22 1982-11-22 Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
DD219200A5 true DD219200A5 (de) 1985-02-27

Family

ID=6178924

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83256872A DD219200A5 (de) 1982-11-22 1983-11-18 Verfahren zur herstellung neuer 6alpha-methylkortikoide

Country Status (22)

Country Link
US (1) US4645763A (es)
EP (1) EP0110041B1 (es)
JP (1) JPS59106500A (es)
AT (1) ATE28651T1 (es)
AU (1) AU2098983A (es)
BG (2) BG42677A3 (es)
CA (1) CA1303607C (es)
CS (1) CS248712B2 (es)
DD (1) DD219200A5 (es)
DE (2) DE3243482A1 (es)
DK (1) DK159686C (es)
ES (1) ES526446A0 (es)
GB (1) GB2130587A (es)
GR (1) GR79725B (es)
HU (1) HU190746B (es)
IE (1) IE56281B1 (es)
IL (1) IL70160A (es)
NO (1) NO157454C (es)
PL (3) PL141686B1 (es)
PT (1) PT77408B (es)
RO (2) RO89343A (es)
ZA (1) ZA838720B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161914A (ja) * 1984-02-02 1985-08-23 Green Cross Corp:The ステロイド脂肪酸エステル含有直腸投与製剤
JPS61274795A (ja) * 1985-05-30 1986-12-04 Toshiba Corp 曝気槽の溶存酸素濃度制御装置
US4968822A (en) * 1987-12-11 1990-11-06 Taisho Pharmaceutical Co., Ltd. 21-alkoxysteroid compounds
EP0523132A1 (en) * 1990-03-27 1993-01-20 Schering Corporation PROCESS FOR 9$g(a)-HYDROXY STEROID DEHYDRATION
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ITMI20011762A1 (it) 2001-08-10 2003-02-10 Cosmo Spa Esteri di 17alfa,21-diidrossipregnene, loro uso come agenti anti-androgenetici e procedimenti per la loro preparazione
ITMI20071616A1 (it) 2007-08-03 2009-02-04 Cosmo Spa Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
KR101591482B1 (ko) * 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
EP3108879A1 (en) 2015-06-25 2016-12-28 Cassiopea S.p.A. High concentration formulation
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053832A (en) * 1957-04-29 1962-09-11 Schering Corp Alkylated cortical steroids
GB921533A (en) * 1958-07-12 1963-03-20 Syntex Sa Cyclopentanophenanthrene derivatives and process for the production thereof
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
US4243586A (en) * 1980-01-18 1981-01-06 E. R. Squibb & Sons, Inc. Steroidal-17-spiro-dihydrofuranones
US4318853A (en) * 1980-01-31 1982-03-09 The Upjohn Company 9β,11β-Epoxy-5β-corticoids
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
EP0054786B1 (de) * 1980-12-23 1985-03-20 Schering Aktiengesellschaft Neue 6-alpha-Methylhydrocortison-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
HU190746B (en) 1986-10-28
RO89343A (ro) 1986-03-15
RO93593B (ro) 1988-01-01
BG43867A3 (en) 1988-08-15
GR79725B (es) 1984-10-31
GB8327736D0 (en) 1983-11-16
PL138796B1 (en) 1986-11-29
IE832708L (en) 1984-05-22
RO93593A (ro) 1987-12-31
DK159686C (da) 1991-04-15
DE3372776D1 (en) 1987-09-03
PL250734A1 (en) 1985-07-30
DK533783D0 (da) 1983-11-22
PL141686B1 (en) 1987-08-31
GB2130587A (en) 1984-06-06
NO157454C (no) 1988-03-23
DK533783A (da) 1984-05-23
AU2098983A (en) 1984-05-31
NO157454B (no) 1987-12-14
DE3243482A1 (de) 1984-05-24
ES8405421A1 (es) 1984-06-16
EP0110041B1 (de) 1987-07-29
PL250735A1 (en) 1985-07-30
PT77408A (de) 1983-10-01
JPH0415799B2 (es) 1992-03-19
DK159686B (da) 1990-11-19
IL70160A0 (en) 1984-02-29
ES526446A0 (es) 1984-06-16
US4645763A (en) 1987-02-24
NO834265L (no) 1984-05-23
CS248712B2 (en) 1987-02-12
EP0110041A1 (de) 1984-06-13
PL244685A1 (en) 1985-04-24
ZA838720B (en) 1984-07-25
PT77408B (de) 1986-02-27
ATE28651T1 (de) 1987-08-15
IE56281B1 (en) 1991-06-05
IL70160A (en) 1988-03-31
BG42677A3 (en) 1988-01-15
JPS59106500A (ja) 1984-06-20
CA1303607C (en) 1992-06-16

Similar Documents

Publication Publication Date Title
EP0135476B1 (de) Steroid Carbonsäureester
EP0072547B1 (de) Neue 6-alpha-Methylprednisolon-Derivate ihre Herstellung und Verwendung
EP0100874B1 (de) Neue 6,16-Dimethylkortikoide, ihre Herstellung und Verwendung
DD219200A5 (de) Verfahren zur herstellung neuer 6alpha-methylkortikoide
EP0072546B1 (de) Neue Hydrocortison-Derivate, ihre Herstellung und Verwendung
DE3102397A1 (de) 17(alpha)-acyloxy-5(beta)-corticoide und 17(alpha)-acyloxy-5(alpha)-corticoide
EP0149464A2 (de) 6-Alpha,16-beta-Dimethylkortikoide
EP0003341B1 (de) 11,17-substituierte Pregnane, ihre Herstellung und Verwendung zur Herstellung von pharmazeutischen Präparaten
DE2743069A1 (de) Verfahren zur herstellung von mehrfach halogenierten steroiden
DD208812A5 (de) Verfahren zur herstellung von 6-alpha-methylhydrocortison-derivaten
EP0149222A2 (de) Neue 6alpha, 16alpha-Dimethylkortikoide
EP0005758B1 (de) Verfahren zum Aufbau der Hydroxyacetyl-Seitenkette von Steroiden des Pregnan-Typs, neue 21-Hydroxy-20-oxo-17alpha-pregnan-Verbindungen und pharmazeutische Präparate enthaltend dieselben
CH630098A5 (en) Process for the preparation of derivatives of 9-chloroprednisolone
EP0164298A2 (de) Neue 6alpha-Methyl-D-homo-kortikoide
DE2645105C2 (de) Derivate des 9-Chlorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
EP0049783B1 (de) D-Homo-kortikoide, ihre Herstellung und Verwendung
EP0144086A2 (de) Neue Hydrocortison- und Prednisolon-Derivate
CH638226A5 (en) Derivatives of 9-fluoroprednisolone
AT253135B (de) Verfahren zur Herstellung neuer Steroidverbindungen
DE2712862C2 (de) Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0112467A1 (de) Neue 6alpha-Methylprednisolon-Derivate ihre Herstellung und Verwendung
EP0078432A1 (de) Neue Kortikoide, ihre Herstellung und Verwendung
DE2855465A1 (de) Neue kortikoide, verfahren zu ihrer herstellung, ihre verwendung und diese kortikoide enthaltende pharmazeutische praeparate
CH631185A5 (en) Multiply halogenated steroids
DE2809732A1 (de) Neue derivate des 9-fluorprednisolons

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee